To investigate whether cGAS-STING is involved in the pathogenesis of diabetic vascular disease, we first searched the available databases and found that STING was significantly upregulated in the leukocytes from type 2 diabetes patients with macrovascular complications (DMCs) in published datasets (Fig. 1a). This evidence concerns the gene CGAS and type 2 diabetes mellitus.